The European long-acting bronchodilator market was valued at around $1.3 billion in 2018 and is anticipated to grow at a substantial rate of 2.6% during the forecast period. Major countries that will contribute to the long-acting bronchodilator market within the region includes UK, Germany, ... Read more

Italy long-acting bronchodilator market is anticipated to grow at a substantial rate of 2.5% during the forecast period. The significant prevalence of asthma and COPD has augmented the demand for long-acting bronchodilators within the country. Moreover, rising tobacco smoking activities in the ... Read more

US green tea market is estimated to grow at a CAGR of around 4% during the forecast period. The tea market is highly competitive in the US. It is comprised of a few US-based tea growers and several importers from almost every tea producing countries, such as China, India, and Japan. However, ... Read more

Asia-Pacific tea and tea-based beverages market was valued at around $18.8 billion in 2018, which is further estimated to reach around $28.2 billion in 2025 at a CAGR of 6.0% during the forecast period. Asia-Pacific is the largest producer and consumer of tea all across the globe. Due to this, ... Read more

China metered dose inhaler market is anticipated to grow at a substantial rate of around 4.0% during the forecast period. High level of air pollution and the significant number of smokers in China is boosting the demand for inhalers in the country. Additionally, the rising geriatric population ... Read more

The Germany genomic biomarker market is estimated to grow significantly at a CAGR of 15.6% during the forecast period. It is due to the increasing geriatric population, the presence of highly specialized urologists for cancer treatment and bit low-cost treatment as compared to UK, which is ... Read more

The UK genomic biomarker market is estimated to grow significantly at a CAGR of more than 15% during the forecast period. The major factors driving market growth include a high prevalence of cancer and chronic diseases in the region. The healthcare expenditure in UK has increased significantly ... Read more

Canada metered dose inhaler market is anticipated to grow at a significant CAGR of around 7.0% during the forecast period. The major factors that are contributing significantly to the market growth include growing geriatric population susceptible to respiratory diseases such as asthma and COPD, ... Read more

Germany metered dose inhaler market is anticipated to grow at a substantial rate of around 4.0% during the forecast period. Germany is one of the key economies of the European region in terms of revenue generation and future opportunities for the metered dose inhaler market. Major factors that ... Read more